双重高剂量化疗增加了儿科固体瘤中二次恶性新生体的风险
Hana Lim1, Minji Im2, Eun Seop Seo1
1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cancer research and treatment
|November 24, 2023
概括
儿童癌症幸存者面临着二次恶性瘤 (SMN) 的高风险,特别是在高剂量化疗 (HDCT) 或显著的放射治疗 (RT) 之后. 优化治疗和长期跟踪对这些年轻患者至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症流行病学 癌症流行病学
- 临床研究 临床研究
背景情况:
- 二次性恶性瘤 (SMN) 是儿童癌症幸存者长期关注的一个重要问题.
- 了解SMN的发病率和风险因素对于改善患者的治疗结果至关重要.
- 双重高剂量化疗 (HDCT) 和放射治疗 (RT) 是常见的治疗方式,具有潜在的长期副作用.
研究的目的:
- 研究小儿固体瘤中SMN的发生率和风险因素.
- 具体评估双重高剂量化疗 (HDCT) 对SMN发展的影响.
- 确定与SMN风险增加相关的患者和治疗特征.
主要方法:
- 在1994年至2014年期间,对1,435名儿科患者 (<19岁) 进行了回顾性分析,这些患者被诊断患有或接受了固体瘤治疗.
- 使用竞争风险方法估计的SMN累积发病率,死亡作为竞争风险.
- 采用多变量分析来识别SMN发展的重大风险因素.
主要成果:
- 10年和20年的SMN累积发病率分别为2.68%和10.19%.
- 显著的SMN风险因素包括放射治疗 (RT) > 2,340 cGy和高剂量化学疗法 (HDCT).
- 常见的SMN包括瘤,瘤和血液恶性瘤,其类型因原发性瘤而异.
结论:
- 在小儿固体瘤患者中,SMN的累积发病率特别高.
- 超过2,340 cGy的双重HDCT和RT剂量是SMN的重要风险因素.
- 治疗强度应该是个性化的,对于儿童癌症幸存者来说,长期随访是必不可少的.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Bone Marrow Sampling and Transplants
334
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
334


